Name | Number of supported studies | Average coverage | |
---|---|---|---|
CD8-positive, alpha-beta T cell | 6 studies | 26% ± 5% | |
natural killer cell | 4 studies | 29% ± 9% | |
CD4-positive, alpha-beta T cell | 4 studies | 31% ± 4% | |
B cell | 3 studies | 21% ± 3% | |
plasmablast | 3 studies | 46% ± 18% | |
hematopoietic precursor cell | 3 studies | 28% ± 12% | |
plasma cell | 3 studies | 28% ± 9% | |
epithelial cell | 3 studies | 22% ± 2% | |
erythroblast | 3 studies | 49% ± 23% | |
T cell | 3 studies | 23% ± 5% | |
erythrocyte | 3 studies | 32% ± 11% | |
effector CD8-positive, alpha-beta T cell | 3 studies | 24% ± 8% |
Insufficient scRNA-seq data for expression of FEN1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 100% | 1362.59 | 1805 / 1809 | 100% | 91.49 | 470 / 472 |
intestine | 99% | 732.85 | 961 / 966 | 99% | 74.69 | 523 / 527 |
bladder | 100% | 425.33 | 21 / 21 | 99% | 85.53 | 497 / 504 |
breast | 99% | 500.50 | 456 / 459 | 99% | 67.83 | 1104 / 1118 |
esophagus | 98% | 766.36 | 1415 / 1445 | 100% | 63.30 | 183 / 183 |
brain | 98% | 829.84 | 2596 / 2642 | 100% | 50.65 | 702 / 705 |
stomach | 97% | 607.71 | 347 / 359 | 99% | 65.49 | 282 / 286 |
prostate | 96% | 447.60 | 234 / 245 | 98% | 30.45 | 490 / 502 |
uterus | 91% | 402.78 | 154 / 170 | 100% | 126.68 | 459 / 459 |
lung | 91% | 549.31 | 525 / 578 | 98% | 64.43 | 1135 / 1155 |
pancreas | 92% | 350.25 | 303 / 328 | 96% | 38.06 | 170 / 178 |
liver | 98% | 522.70 | 221 / 226 | 89% | 40.61 | 360 / 406 |
ovary | 86% | 373.86 | 155 / 180 | 98% | 41.88 | 421 / 430 |
adrenal gland | 100% | 974.36 | 258 / 258 | 82% | 29.27 | 189 / 230 |
thymus | 90% | 287.53 | 586 / 653 | 89% | 33.38 | 538 / 605 |
kidney | 91% | 373.49 | 81 / 89 | 81% | 19.79 | 727 / 901 |
lymph node | 0% | 0 | 0 / 0 | 100% | 197.39 | 29 / 29 |
tonsil | 0% | 0 | 0 / 0 | 100% | 133.07 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 75.18 | 1 / 1 |
muscle | 100% | 751.22 | 802 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1276.99 | 240 / 241 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 38.58 | 78 / 80 |
adipose | 97% | 488.37 | 1167 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 84% | 302.84 | 1128 / 1335 | 0% | 0 | 0 / 0 |
heart | 81% | 308.86 | 698 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 78% | 1868.00 | 727 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006281 | Biological process | DNA repair |
GO_0090304 | Biological process | nucleic acid metabolic process |
GO_0009650 | Biological process | UV protection |
GO_0006287 | Biological process | base-excision repair, gap-filling |
GO_0006302 | Biological process | double-strand break repair |
GO_0006260 | Biological process | DNA replication |
GO_0045876 | Biological process | positive regulation of sister chromatid cohesion |
GO_0000724 | Biological process | double-strand break repair via homologous recombination |
GO_0032201 | Biological process | telomere maintenance via semi-conservative replication |
GO_0007613 | Biological process | memory |
GO_0043137 | Biological process | DNA replication, removal of RNA primer |
GO_0005730 | Cellular component | nucleolus |
GO_0016020 | Cellular component | membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0000781 | Cellular component | chromosome, telomeric region |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0004527 | Molecular function | exonuclease activity |
GO_0008409 | Molecular function | 5'-3' exonuclease activity |
GO_0004519 | Molecular function | endonuclease activity |
GO_0003690 | Molecular function | double-stranded DNA binding |
GO_0004523 | Molecular function | RNA-DNA hybrid ribonuclease activity |
GO_0017108 | Molecular function | 5'-flap endonuclease activity |
GO_0000287 | Molecular function | magnesium ion binding |
GO_0030145 | Molecular function | manganese ion binding |
GO_0048256 | Molecular function | flap endonuclease activity |
GO_0008309 | Molecular function | double-stranded DNA exodeoxyribonuclease activity |
GO_0005515 | Molecular function | protein binding |
GO_0003684 | Molecular function | damaged DNA binding |
Gene name | FEN1 |
Protein name | Flap endonuclease 1 (FEN-1) (EC 3.1.-.-) (DNase IV) (Flap structure-specific endonuclease 1) (Maturation factor 1) (MF1) (hFEN-1) Flap structure-specific endonuclease 1 Flap endonuclease 1 (FEN-1) (EC 3.1.-.-) (Flap structure-specific endonuclease 1) |
Synonyms | RAD2 hCG_40848 |
Description | FUNCTION: Structure-specific nuclease with 5'-flap endonuclease and 5'-3' exonuclease activities involved in DNA replication and repair. During DNA replication, cleaves the 5'-overhanging flap structure that is generated by displacement synthesis when DNA polymerase encounters the 5'-end of a downstream Okazaki fragment. It enters the flap from the 5'-end and then tracks to cleave the flap base, leaving a nick for ligation. Also involved in the long patch base excision repair (LP-BER) pathway, by cleaving within the apurinic/apyrimidinic (AP) site-terminated flap. Acts as a genome stabilization factor that prevents flaps from equilibrating into structures that lead to duplications and deletions. Also possesses 5'-3' exonuclease activity on nicked or gapped double-stranded DNA, and exhibits RNase H activity. Also involved in replication and repair of rDNA and in repairing mitochondrial DNA. . FUNCTION: Structure-specific nuclease with 5'-flap endonuclease and 5'-3' exonuclease activities involved in DNA replication and repair. During DNA replication, cleaves the 5'-overhanging flap structure that is generated by displacement synthesis when DNA polymerase encounters the 5'-end of a downstream Okazaki fragment. It enters the flap from the 5'-end and then tracks to cleave the flap base, leaving a nick for ligation. Also involved in the long patch base excision repair (LP-BER) pathway, by cleaving within the apurinic/apyrimidinic (AP) site-terminated flap. Acts as a genome stabilization factor that prevents flaps from equilibrating into structures that lead to duplications and deletions. Also possesses 5'-3' exonuclease activity on nicked or gapped double-stranded DNA, and exhibits RNase H activity. Also involved in replication and repair of rDNA and in repairing mitochondrial DNA. . |
Accessions | ENST00000305885.3 [P39748-1] P39748 Q6FHX6 F5H1Y3 ENST00000535723.1 ENST00000535307.1 I3L3E9 |